Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

CStone receives IND approval in China for HDAC6 inhibitor CS3003

biospectrumasiaMarch 13, 2019

Tag: CStone Pharmaceuticals , IND approval , HDAC6 inhibitor

PharmaSources Customer Service